Shankar LAL Rampal Ltd
NSE: SRD · Trading - Chemicals · sector
₹38.60NSE close 2026-10-26
Key numbers
Market cap₹247 cr
Price₹38.60
52w high / low₹75 / ₹36
P/E13.4xSector median 20.4x
P/B2.0xSector median 0.8x
Book value₹19.2
Dividend yield0.13%Sector median 0.57%
ROE15.9%Sector median 5.6%
ROCE17.4%Sector median 8.7%
OPM5.4%Sector median 2.0%
Debt / equity0.21xSector median 0.15x
EV/EBITDA10.5xSector median 12.1x
Interest cover24.5x
Current ratio4.69x
Sales growth 3y–Sector median +17.1%
Profit growth 3y–Sector median -7.2%
PEG0.26x
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 13 companies in Trading - Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹0 cr vs borrowings ₹25 cr (FY26): borrowings are higher by ₹25 cr.
- Operating profit covered interest 24.5x in the last 12 months.
- Revenue was higher than a year earlier in 3 of the last 4 quarters.
- Other income was 0% of net profit in the last 12 months.
- Dividend paid in 1 of the last 2 financial years.
- Price ₹38.60 on 2026-10-26: -48.5% from the 52-week high, +7.5% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹112.50 · low ₹36.80
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 94 | 102 | 107 | 122 | 113 | 91 | 139 | 136 |
| EBITDA | 4 | 4 | 4 | 6 | 4 | 3 | 7 | 13 |
| OPM % | 3.9% | 4.1% | 3.6% | 5.1% | 3.4% | 2.9% | 4.9% | 9.4% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | 3 | 3 | 3 | 4 | 2 | 2 | 5 | 9 |
| EPS (₹) | 0.40 | 0.45 | 0.39 | 0.66 | 0.37 | 0.33 | 0.75 | 1.44 |
| Revenue YoY | +19.4% | -11.1% | +30.5% | +10.9% | ||||
| Profit YoY | -6.3% | -27.3% | +90.5% | +116.7% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY25 | FY26 | TTM |
|---|---|---|---|
| Revenue | 402 | 465 | 478 |
| EBITDA | 16 | 19 | 26 |
| Net profit | 11 | 13 | 18 |
| EPS (₹) | 1.78 | 2.11 | 2.89 |
| Revenue growth | +15.7% | +12.4% | |
| Profit growth | +18.4% | +51.8% | |
| Dividend / share (₹) | – | 0.05 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | +12.4% |
| Net profit | – | – | +51.8% |
| EPS | – | – | – |
| Share price | – | -38.1% (2y) | -48.1% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 110 | 123 |
| Borrowings | 18 | 25 |
| Cash & equivalents | 1 | 0 |
| Total assets | 129 | 157 |
| Fixed assets | 1 | 1 |
| Capital work in progress | 0 | 0 |
| Investments | 0 | 0 |
| Receivables | 76 | 102 |
| Inventory | 13 | 15 |
| Payables | 1 | 6 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | -13 | -7 |
| Cash from investing | 0 | -0 |
| Cash from financing | 10 | 6 |
| Capex | 0 | 0 |
| Free cash flow | -13 | -7 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 10.4% | 11.0% |
| ROCE % | 12.8% | 13.0% |
| Debtor days | 69 | 80 |
| Inventory days | 12 | 12 |
| Payable days | 1 | 5 |
| Cash conversion cycle (days) | 80 | 87 |
| Working capital days | 99 | 95 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 73.61% |
| FIIs | 0.04% |
| DIIs | 0.00% |
| of which Mutual funds | 0.00% |
| of which Insurance | 0.00% |
| Government | 0.00% |
| Public (non-institutions) | 26.36% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 73.84% | 73.61% | 73.61% | 73.61% | 73.61% | 73.61% | 73.61% | 73.61% |
| Promoter group | % |
|---|---|
| Oasis Capital Private Limited | 10.84% |
| Classic Prime Home Care Private Limited | 8.18% |
| Susheel Kumar Inani | 6.63% |
| Vinod Kumar Inani | 5.99% |
| Jagdish Chandra Inani | 5.76% |
| Dinesh Chandra Inani | 5.02% |
| Mamta Inani | 4.56% |
| Rampal Inani | 4.51% |
| Kiran Inani | 3.99% |
| Sheelu Inani | 3.76% |
| Meena Inani | 3.20% |
| Rampal Inani HUF | 2.60% |
| Ganga Devi Inani | 2.11% |
| Usha Inani | 2.06% |
| Jagdish Chandra Inani HUF | 0.83% |
| Public holders above 1% | % |
|---|---|
| Dwarka Prasad Bhadada | 1.77% |
| Krishna Gopal Kabra | 1.62% |
| Pinki Devi Agal | 1.50% |
| Amit Bhadada | 1.17% |
13,706 shareholders. Pledged: – of promoter shares.
Peers in Trading - Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| UNIENTER | ₹604 cr | 29.9x | 0.2x | 0.8% | 0.8% | -15.6% | +179.1% | 0.57% |
| VINYLINDIA | ₹440 cr | 23.6x | 3.4x | 14.5% | 19.2% | 2.0% | -13.6% | 2.92% |
| VERITAS | ₹389 cr | 12.5x | 0.1x | -0.0% | 0.8% | 2.0% | +139.0% | 0.03% |
| EVEXIA | ₹325 cr | – | 0.8x | 0.4% | 0.5% | 1.7% | +17.1% | – |
| BHAVIK | ₹303 cr | 22.4x | 2.1x | 9.3% | 12.9% | 2.7% | – | – |
| SRD | ₹247 cr | 13.4x | 2.0x | 15.9% | 17.4% | 5.4% | – | 0.13% |
| A1L | ₹225 cr | 20.4x | 4.2x | 16.5% | 14.3% | 3.6% | +1.2% | 0.76% |
| SHIVTEXCHEM | ₹154 cr | 2.0x | 0.4x | 22.3% | 36.6% | 4.9% | – | – |
| YASHCHEM | ₹51 cr | 21.2x | 1.2x | 5.6% | 8.7% | 0.2% | +38.3% | – |
| AUREATE | ₹45 cr | 8.6x | 5.0x | 57.7% | 108.9% | 6.0% | – | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-11 | Dividend | Dividend - Re 0.05 Per Share |
| 2025-09-19 | Dividend | Dividend - Rs 0.05 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Announcements NSE filings
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
| Sector | Commodities |
| Industry | Trading - Chemicals |
| Sub-industry | Trading - Chemicals |
| Symbol | SRD |
| BSE code | 542232 |
| ISIN | INE01NE01012 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.